Navigation Links
KLOX Technologies annonce qu'elle a obtenu l'approbation européenne du marquage CE sur son produit novateur et non invasif pour l'acné simple
Date:11/19/2013

système LumiCleanse[TM]
Le système LumiCleanse[TM] est composé de multiples ampoules à DEL qui activent un gel convertisseur-photo topique et qu'on applique sur la zone atteinte pour obtenir des résultats efficaces et sécuritaires dans le traitement de l'acné simple. Le système cible les problèmes sous-jacents qui causent l'acné simple en plus de stimuler la production de collagène par la peau affectée. Il est conçu pour favoriser la guérison de l'épiderme et du derme profond d'une façon non invasive. Le cycle de traitement, qui comprend la préparation, ne dure que 15 minutes et doit être répété deux fois par semaine, pendant six semaines. La technologie est non abrasive et non thermique en plus de ne pas causer d'inconfort chez le patient.

À propos de KLOX Technologies : capitaliser sur les technologies biophotoniques fondées sur la lumière
Située à Laval, au Québec, KLOX est une société à capital fermé qui se spécialise dans le développement d'une technologie biophotonique unique, non invasive et protégée par un portefeuille de brevets exploitant un système lumineux multiple DEL qui interagit avec un gel riche en oxygène contenant des molécules captant la lumière. Les cosmétiques et appareils médicaux de KLOX sont destinés aux marchés à croissance rapide des domaines cosmétiques, dermatologiques et de la réparation des tissus.

Pour des renseignements supplémentaires, veuillez consulter le site Internet de l'entreprise: http://www.kloxtechnologies.com.

Énoncés prospectifs
Certains énoncés contenus dans ce document, autres que les 
'/>"/>

SOURCE Klox Technologies Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. UV Flu Technologies Expands Its International Footprint
3. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
4. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
5. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
6. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
7. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
8. Animal Biotechnology - Technologies, Markets and Companies
9. Gene Therapy - Technologies, Markets and Companies
10. Biomarkers - Technologies, Markets and Companies
11. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 ... announced the addition of the "Global PDT ... offering.        (Logo: ... Report 2014 is a professional and in-depth study ... , ,The report provides a basic overview of ...
(Date:6/1/2015)... 2015  Boston-based Veritas Genetics is launching its ... bring personalized medicine and prevention to the forefront, ... health. Beginning with its first product, a genetic ... Veritas Genetics is making its products affordable and ... of genetic data which will be shared with ...
(Date:6/1/2015)... La. , June 1, 2015 Esperance ... II trial of lead candidate EP-100 in ovarian cancer ... peptide designed to seek and destroy cancer cells that ... LHRH receptors are over-expressed in a wide range of ... multi-center Phase II trial of EP-100 were presented ...
(Date:6/1/2015)... , June 1, 2015 ... that it will be participating in the Jefferies 2015 ... on Tuesday, June 2, 2015. Jeff ... question and answer session at 10:00 a.m. ET (3:00 ... be available on the Presentations and Webcasts section of ...
Breaking Biology Technology:Global PDT Machine Industry Report 2014 2Veritas Genetics To Advance Precision Medicine And Disease Prevention 2Veritas Genetics To Advance Precision Medicine And Disease Prevention 3Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3
... Aug. 4 OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), ... clinical trials announced today that the company has acquired the ... Ltd. The acquisition will be operated by OmniComm,s UK subsidiary, ... exceptional software is used to collect clinical trial data gathered ...
... molecule-sized pores are one step closer to replacing the ... of academic researchers is reporting. Writing this week ... membranes, ability to separate molecules in a mixture is ... processing (RTP). By heating the membranes from room temperature ...
... , , SAN FRANCISCO, Aug. ... positive drug sales/earnings and partnering and M&A deals. As a result, ... 6.5 percent, mirroring the Dow and Nasdaq, which closed the month ... for a July in years. , , Helping ...
Cached Biology Technology:OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd. 2OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd. 3Rapid heating prepares energy-saving zeolite for greater role in industrial separations 2Rapid heating prepares energy-saving zeolite for greater role in industrial separations 3Rapid heating prepares energy-saving zeolite for greater role in industrial separations 4Biotech Hot in July Driven by Positive Drug Data and Acquisitions 2Biotech Hot in July Driven by Positive Drug Data and Acquisitions 3Biotech Hot in July Driven by Positive Drug Data and Acquisitions 4Biotech Hot in July Driven by Positive Drug Data and Acquisitions 5
(Date:5/22/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... promotional pricing and making the Wocket generally available for $229 ... Head of Marketing said, "We,ve extended the opportunity to take ... May. To get your wocket at this special price, submit ... on June 1, you,ll receive a unique code that gives ...
(Date:5/20/2015)... 2015 Research ... the addition of the  "5-year Opportunity ... Market"  report to their offering.  ,     ... analyses trends in the iris recognition ... sectors, globally. Despite hardware pricing and ...
(Date:5/19/2015)... DUBLIN , May 19, 2015 /PRNewswire/ ... ) has announced the addition of the  ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A ... provides an in-depth analysis of the current ... introduction of gene-based tests, their working principles ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... at land-grant universities are a major source of ... industry. To prepare future employees for work in ... in nursery management and production, but availability of ... horticulture programs have contributed to a reduction in ...
... 2011 Dr. Daniel Von Hoff was presented this month ... in sequencing, or spelling out, the DNA of patients with ... advances the art of using the fully sequenced genomes of ... DNA, to help determine the best course of treatment. ...
... Mich. (March 17, 2011) In a ... so-called "orphan" nuclear receptor TR4, Van Andel Research Institute ... more direct role than was previously known in certain ... of the central nervous system. Scientists had previously ...
Cached Biology News:Integrating instructional multimedia in nursery management, production courses 2Dr. Daniel Von Hoff presented with top genomics award from Scripps 2Study indicates vitamin A plays key role in the human body 2
Mouse monoclonal antibody raised against a partial recombinant FBXO24. NCBI Entrez Gene ID = FBXO24...
Mouse monoclonal antibody raised against a partial recombinant CALCOCO2. NCBI Entrez Gene ID = CALCOCO2...
Mouse monoclonal to Casein Kinase 2 beta ( Abpromise for all tested applications). entrezGeneID: 1460 SwissProtID: P13862...
...
Biology Products: